600 results on '"Danner, S."'
Search Results
152. Epidemiology of cryptosporidiosis among European AIDS patients.
153. No Beneficial Effect of Interferon- Treatment in 2 Human Immunodeficiency Virus-Infected Patients with Mycobacterium avium Complex Infection
154. Factors associated with the development of Pneumocystis carinii pneumonia in 5,025 European patients with AIDS. AIDS in Europe Study Group.
155. Mouse models of α-synucleinopathy and Lewy pathology
156. Sexual Transmission and Propagation of SIV and HIV in Resting and Activated CD4 + T Cells
157. New Antimycobacterial Saponin from Colubrina retusa
158. Impact of diarrhoea and faecal incontinence on the daily life of HIV-infected patients
159. Effects of protease inhibitors on the course of CMV retinitis in relation to CD4+ lymphocyte responses in HIV+ patients
160. Selective inhibition of syncytium-inducing and nonsyncytium-inducing HIV-1 variants in individuals receiving didanosine or zidovudine, respectively.
161. Prevalence ofCampylobacter‐Associated Diarrhea Among Patients Infected with Human Immunodeficiency Virus
162. Conversion rate towards a syncytium inducing (SI) phenotype during different stages of HIV infection and prognostic value of SI phenotype for survival after aids diagnoses
163. Regulators of G-protein-mediated signalling
164. Phosducin is a ubiquitous G-protein regulator.
165. Health care systems in transition: the Netherlands: Part II: The response of the Dutch health care system to HIV-AIDS
166. Epidemiology of cryptosporidiosis among European AIDS patients.
167. Mechanisms of ?-adrenergic receptor desensitization: from molecular biology to heart failure
168. Major complications in HIV-infected patients with perianal sepsis
169. Evaluation of Safety and Efficacy of 3TC (Lamivudine) in Patients with Asymptomatic or Mildly Symptomatic Human Immunodeficiency Virus Infection: A Phase I/II Study
170. OFD - Teambasıertes Entwickeln kundengerechter Produkte / OFD - Team-based development ofproducts conforming to customers
171. Combined zidovudine and interferon-alpha treatment in patients with AIDS-associated Kaposi's sarcoma
172. Failure to maintain high-dose treatment regimens during long-term use of zidovudine in patients with symptomatic human immunodeficiency virus type 1 infection.
173. A947 ENDOTHELIN LEVELS IN PATIENTS WITH PREECLAMPSIA
174. Can the course of high dose cotrimoxazole forPneumocystis cariniipneumonia in AIDS be shorter? A possible solution to the problem of cotrimoxazole toxicity
175. Expression of human β-secretase in the mouse brain increases the steady-state level of β-amyloid.
176. Risk Factors for Hepatotoxicity in HIV-Infected Patients Receiving Ritonavir and Saquinavir with or without Stavudine.
177. Common health problems in HIV-infected travelers to the (sub)tropics.
178. Autoimmunity against blood cells in human immunodeficiency-virus (HIV) infection.
179. Echocardiographic dimensions and maximal oxygen uptake in oarsmen during training.
180. Cultured human thymus epithelial monolayer cells induce CD4 expression on mononuclear cells of AIDS patients in vitro.
181. Prevalence of Campylobacter-Associated Diarrhea Among Patients Infected with Human Immunodeficiency Virus.
182. Factors Associated with the Development of Pneumocystis carinii Pneumonia in 5,025 European Patients with AIDS.
183. Implantation of cultured thymic fragments in patients with acquired immunodeficiency syndrome
184. Safety and complications of central venous catheters in AIDS patients
185. Summary of the international consensus symposium on management of HIV, CMV and hepatitis virus infections
186. Agonist regulation of human beta2-adrenergic receptor mRNA stability occurs via a specific AU-rich element.
187. Upregulation of vascular endothelial growth factor in severe chronic brain hypoxia of the rat
188. Phosducin, potential role in modulation of olfactory signaling.
189. Cell type-specific regulation of ~2-adrenoceptor mRNA by agonists
190. Antigen-specific T-lymphocyte proliferative responses during highly active antiretroviral therapy (HAART) of HIV-I infection
191. Failure to maintain high-dose treatment regimens during long-term use of zidovudine in patients with symptomatic human immunodeficiency virus type 1 infection.
192. AIDS, a clinical diagnosis and hence one with pitfalls
193. Acquired immunodeficiency syndrome
194. Acquired immune deficiency syndrome, altered T cell subset ratios, and cytomegalovirus infections among male homosexuals in The Netherlands
195. Cellular and humoral immunity in various cohorts of male homosexuals in relation to infection with human immunodeficiency virus
196. Decline of antibody reactivity to outer viral core protein p17 is an earlier serological marker of disease progression in human immunodeficiency virus infection than anti-p24 decline
197. Ziekteverschijnselen en klinisch beloop bij de eerste honderd patiënten met AIDS
198. Resumption of HIV antigen production during continuous zidovudine treatment
199. Signs, symptoms and clinical course in the first one hundred patients with AIDS
200. Modified criteria for the diagnosis of AIDS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.